Inspired by you
We are inspired by the resilience of people living with diabetes. We're thrilled to hear you are having a positive experience and we are with you on this journey.
Take a sneak peek into the future of diabetes technology from Medtronic
We have a dedicated focus on what's next to help reduce the day-to-day management of living with diabetes. Check out what we have planned.
Real-life stories
April loves how the system makes the complexity of food management more manageable. With its advanced SmartGuard™ technology, the MiniMed™ 780G system helps April in managing her sugar levels even when she eats foods that are harder to manage.*Φ
Lauren Cox is the first ever WNBA player living with type 1 diabetes. We’re thrilled to be partnering with her to bring more awareness to diabetes and Medtronic technologies! Hear her story.Φ
Allison loves to be active outside. With the MiniMed™ 780G system, she has more freedom to do what she loves and her parents can worry less.Φ
Sage's story
Sage transitioned to the MiniMed™ 670G system so she could worry less about her diabetes management and focus more on her Olympic training. Hear her story.Φ
Luke's story
Luke is a drummer, bike rider, travel enthusiast, and has type 1 diabetes. Hear his story about his diabetes journey.Φ
Using his insulin pump to his advantage: meet #MedtronicChampion Jean-SebastienΦ
A love story that withstands the highs and lows - Jaime's storyΦ
Living life as a high school freshman while having diabetes - Andrew's storyΦ
Aspiring to be a superhero mom - Melanie's storyΦ
A busy flight attendant and bride-to-be - Mandy's storyΦ
A wedding with diabetes - Gina's storyΦ
Share your stories
If you have a story you would like to share, connect with us on our social channels or share a post using: #LiveMoreWorryLess #MedtronicDiabetes
Connect with real people living with diabetes to discuss their experiences
Φ The testimonial above relates an account of an individual’s experience using a Medtronic device. The account is genuine, typical and documented. However, this individual’s experience does not provide any indication, guide, warranty or guarantee as to the response or experience other people may have using the device. The experience other individuals have with the device could be different. Experiences can and do vary. Please talk to your doctor about your condition and the risks and benefits of Medtronic devices.
Sage and Nicky were compensated for spending the day with us and allowing us to photograph them. Their thoughts and opinions are their own. Individual results may vary.
Gina and Amanda are employees of Medtronic. Their thoughts and opinions are their own.
Important Safety Information: MiniMed™ 670G System
The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, seven years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.
WARNING: Medtronic performed an evaluation of the MiniMed™ 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library.
MiniMed is a registered trademark and SmartGuard is a trademark of Medtronic, MiniMed Inc.